These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21881509)

  • 1. Pulmonary exacerbations in cystic fibrosis.
    Stenbit AE; Flume PA
    Curr Opin Pulm Med; 2011 Nov; 17(6):442-7. PubMed ID: 21881509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary exacerbations in cystic fibrosis.
    Rabin HR; Butler SM; Wohl ME; Geller DE; Colin AA; Schidlow DV; Johnson CA; Konstan MW; Regelmann WE;
    Pediatr Pulmonol; 2004 May; 37(5):400-6. PubMed ID: 15095322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to treating cystic fibrosis pulmonary exacerbations varies widely across US CF care centers.
    Kraynack NC; Gothard MD; Falletta LM; McBride JT
    Pediatr Pulmonol; 2011 Sep; 46(9):870-81. PubMed ID: 21465675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation frequency and clinical outcomes in adult patients with cystic fibrosis.
    de Boer K; Vandemheen KL; Tullis E; Doucette S; Fergusson D; Freitag A; Paterson N; Jackson M; Lougheed MD; Kumar V; Aaron SD
    Thorax; 2011 Aug; 66(8):680-5. PubMed ID: 21680566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.
    Flume PA; Mogayzel PJ; Robinson KA; Rosenblatt RL; Quittell L; Marshall BC; ;
    Am J Respir Crit Care Med; 2010 Aug; 182(3):298-306. PubMed ID: 20675678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations.
    Flume PA; Mogayzel PJ; Robinson KA; Goss CH; Rosenblatt RL; Kuhn RJ; Marshall BC;
    Am J Respir Crit Care Med; 2009 Nov; 180(9):802-8. PubMed ID: 19729669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical approach to lung disease in patients with cystic fibrosis.
    O'Sullivan BP; Flume P
    Semin Respir Crit Care Med; 2009 Oct; 30(5):505-13. PubMed ID: 19760538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials.
    Mayer-Hamblett N; Saiman L; Lands LC; Anstead M; Rosenfeld M; Kloster M; Fisher L; Ratjen F
    Contemp Clin Trials; 2013 Sep; 36(1):99-105. PubMed ID: 23770109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary exacerbations in CF patients with early lung disease.
    Anstead M; Saiman L; Mayer-Hamblett N; Lands LC; Kloster M; Goss CH; Rose L; Burns JL; Marshall B; Ratjen F
    J Cyst Fibros; 2014 Jan; 13(1):74-9. PubMed ID: 24029220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients.
    Waters VJ; Stanojevic S; Sonneveld N; Klingel M; Grasemann H; Yau YC; Tullis E; Wilcox P; Freitag A; Chilvers M; Ratjen FA
    J Cyst Fibros; 2015 Nov; 14(6):755-62. PubMed ID: 25690407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.
    Waters V; Stanojevic S; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    Eur Respir J; 2012 Jul; 40(1):61-6. PubMed ID: 22135280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early detection of exacerbation of lung infections in patients with cystic fibrosis by means of daily spirometry].
    Izbicki G; Trachsel D; Rutishauser M; Perruchoud AP; Tamm M
    Schweiz Med Wochenschr; 2000 Sep; 130(39):1361-5. PubMed ID: 11059026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on treatment of pulmonary exacerbations in cystic fibrosis.
    Smyth A
    Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exacerbations in noncystic fibrosis bronchiectasis: Clinical features and investigations.
    Kapur N; Masters IB; Chang AB
    Respir Med; 2009 Nov; 103(11):1681-7. PubMed ID: 19501498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis.
    Kapur N; Masters IB; Morris PS; Galligan J; Ware R; Chang AB
    Pediatr Pulmonol; 2012 Jan; 47(1):68-75. PubMed ID: 21830316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
    Waters V; Stanojevic S; Klingel M; Chiang J; Sonneveld N; Kukkar R; Tullis E; Ratjen F
    J Cyst Fibros; 2015 Nov; 14(6):770-6. PubMed ID: 26265220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary complications in cystic fibrosis].
    Rutishauser M
    Schweiz Med Wochenschr; 1991 Jan; 121(4):115-8. PubMed ID: 2003207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.